References
- YANAGISAWA M, KURIHARA H, KIMURA et al.: Nature. (1988) 332:411–415.
- MASAKI T et at: Cardiovascular Drug Rev. (1990)4:373–385.
- DOHERTY AM et at.: Ann. Rep. Med. Chem. (1992) 27:79–88.
- LERMAN A et at: Mayo Clin. Proc. (1990) 65: 1441–1445.
- RANDALL MD et at: Pharm Ther. (1991) 50:73–93.
- DOHERTY AM et at.: J. Med. Chem. (1992) 35:1493–1508.
- YANAGISAWA M et at.: Nature (1988) 332:411–415.
- YANAGISAWA M et at.: Proc. Natl. Acad. Sci USA (1988) 38:1877–1883
- YANAGISAWA M et at.: Biochem. Pharmacol. (1989) 38:1877–1883
- SOGABE K et at.: J. Pharmacol. Exp. Res. (1993) 3:1010-1046 ha.DOHERTY AM: J.Med.Chem. (1992) 35:1493–1508.
- b. DOHERTY AM: EXp Opin. Ther. Patents (1994) 4(5):531–542
- CLOZEL M, BREU V, BURRI K, etal.: Nature. (1993) 365:759–761.
- OHASHI et at.: J. Antibiot. (1992) 45(10):1684–1685.
- MUGRACE B et at.: Btoorg. Med. Chem. Lett. (1993) 3:2099–2104.
- MIHARA S et at.: Eur. J. Pharmacol. (1993) 246:33–38.
- F HOFFMANN-LA ROCHE & CO AG, EP-510526-Al.
- F HOFFMANN-LA ROCHE & CO AG, EP–526708–A1.
- SMITHKLINE BEECHAM CORP, W09308799.
- BLTRRI K et at., EP-510526, 1991.
- COUSINS R etal., W09308799, 1991.
- TAKEDA CHEM IND LTD, EP–562599–A1.
- BRISTOL-MYERS SQUIBB CO, US5248673 A.